+ Victorian Cytology Service +

+. Vision || +. VCS Annual Reports

A government funded pathology laboratory, Victorian Cytology Service (VCS) is primarily responsible for reporting cervical cytology tests. It is the largest single laboratory reporting Pap tests in Australia, examining approximately 280,000 Pap smears per year. This represents approximately half of the smears taken annually in Victoria.

Benefits and Features of the Service
	VCS specialises in cervical cytology.	VCS courier service collects smears and delivers reports in greater Melbourne and major Victorian country centres.
	VCS Pap smear reporting provides a free service for women.	Reply Paid Post is available to other practitioners.
	VCS offers a flexible follow-up protocol enabling practitioners to choose from a range of options.	VCS Liaison Physician Dr Stella Heley is available to discuss aspects of the cervical screening program with practitioners either by telephone or by visiting in person.
	VCS provides comprehensive cytology training and undertakes cervical cytology research.	Pathologists are available at all times to discuss reports with referring practitioners.
	VCS offers a competitive turnaround time.	Statistical reports are sent to practitioners regularly.
	ThinPrep tests can be sent to VCS.	VCS offers educational workshops for GPs.
	VCS offers electronic transfer of results to practitioners with access to Medical Director®, Medical Spectrum, Genie, MedTech32, RX Medical, MIMS or Locum.	VCS provides information brochures for women.
	Stationery is available which enables practitioners to use appropriate software to generate request forms.

VCS also provides a pathology service for the reporting of histological (biopsy) specimens which covers cervical biopsies, small surgical biopsies, skin etc.

We also offer a non-gynaecological cytology service examining fine needle aspiration biopsies, urine and sputum samples, effusions, and other endoscopically obtained samples.

Both of these services may be bulk-billed.

“To play a leading role in the reduction in the impact of cervical pre cancer, cancer, and Chlamydia infection in Australians through the provision of laboratory and registry services, program evaluation, education and research.”